PHARMAC announces decision to fund Trikafta

7 March 2023 - Pharmac has today confirmed the funding of elexacaftor with tezacaftor and ivacaftor (Trikafta) for people with cystic ...

Read more →

PHARMAC seeking feedback on funding Trikafta

4 December 2022 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund Trikafta. ...

Read more →

Why non-funding of cystic fibrosis treatment is unacceptable

30 September 2022 - Edward Lee has self-funded the Trikafta drug that alleviates the symptoms of his cystic fibrosis since 2019. ...

Read more →

My brother is dying while there's a drug that could stop this

26 September 2022 - PHARMAC announced on Friday last week that Trikafta, a potentially life-saving drug for those suffering with ...

Read more →

PHARMAC can't progress cystic fibrosis drug Trikafta - CF New Zealand

16 September 2022 - PHARMAC is not in a position to progress funding on the life-extending cystic fibrosis drug, Trikafta, ...

Read more →

Access criteria for new COVID-19 treatment announced

25 August 2022 - PHARMAC has today confirmed the access criteria for the first preventative medicine for COVID-19, tixagevimab and cilgavimab ...

Read more →

PHARMAC estimates Trikafta could give people with CF another 27 years

17 August 2022 - PHARMAC has today published the record of advice from the May PTAC meeting to again consider ...

Read more →

Accuretic users annoyed over contaminated blood pressure medication muddle

4 July 2022 - Confusion continues as Kiwis learn months after the rest of the world that widely used blood ...

Read more →

Accuretic supply issue, almost 36,000 New Zealanders taking the blood pressure medicine will need to change treatments

30 June 2022 - PHARMAC has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier ...

Read more →

Mum and son hold their breath for cystic fibrosis drug Trikafta ahead of Budget

29 April 2022 - Hamish Mountfort is a smart, well-spoken and confident 22-year-old who’s dying, literally, to dedicate his life ...

Read more →

Funding Trikafta for Kiwis with cystic fibrosis - setting the record straight

31 March 2022 - On Monday 28 March, Carmen Shanks presented her Parliamentary Petition to MP Shanan Halbert, urging the ...

Read more →

Te Pāti Māori demand accountability from PHARMAC CE for lie about live saving Trikafta drug cost

28 March 2022 - Today Te Pāti Māori stand in solidarity with the cystic fibrosis community of Aotearoa New Zealand ...

Read more →

Cystic fibrosis community disappointed with PTAC recommendations

23 February 2022 - New Zealand’s cystic fibrosis community received disappointing news today with a recommendation to PHARMAC that reduces ...

Read more →

PHARMAC recommends funding cystic fibrosis medicine Trikafta but needs more funding

23 February 2022 - PHARMAC’s clinical experts are recommending cystic fibrosis drug Trikafta be funded for those aged over 12 ...

Read more →

PHARMAC’s clinical experts recommend funding Trikafta

23 February 2022 - PHARMAC today announces its clinical advisory committee PTAC has recommended funding cystic fibrosis treatment Trikafta with ...

Read more →